June 23, 2011

Stockholm, June 23, 2011 – NASDAQ OMX (NASDAQ:NDAQ) announces that Boule Diagnostics AB (BOUL), a small cap company within the healthcare sector, today starts trading of its shares on the main market of NASDAQ OMX Stockholm.

Boule Diagnostics AB is an international group of companies with subsidiaries in Sweden, the US and China. Since its inception in 1992, Boule Diagnostics has rapidly grown into an international diagnostics company that develops, manufactures and sells complete solutions with both instruments and consumables for blood diagnostics.

Read more about Boule Diagnostics »

Follow Boule Diagnostics AB´s share information here »

View the film from the listing ceremony on June 23, 2011 here »

Ernst Westman, CEO of Boule Diagnostics is welcomed by Marie Parck, Head of Sales, Listings and Capital Markets, NASDAQ OMX.
Ernst Westman receives a listing crystal from NASDAQ OMX, as a memory of the first day of trading.

Mr Westman awaits the first trade in the share of Boule Diagnostics.
Representatives from Boule Diagnostics AB gathered together with their Advisors and the NASDAQ OMX team to celebrate the first day of trading.